A Birth Cohort Analysis of Amnestic Mild Cognitive Impairment Incidence in the Einstein Aging Study (EAS) Cohort

Manuscript Number: 

18-1141R2

Author(s): 
Carol A. Derby, Charles B. Hall, Mindy J. Katz, Richard B. Lipton, Sara Rozner

Disclosures

Carol A. Derby

  • Equity:
    Mutual funds, Retirement funds

Charles B. Hall

  • Consulting Fees:
    Member National Institutes of Health Study Section. Member External Advisory Committee for National Institute of Aging sponsored Program Projects at Washington University St. Louis. Member Data Safety Monitoring Committee for National Institute of Aging sponsored Research Project at University of Iowa.

Mindy J. Katz

  • Nothing to Disclose

Richard B. Lipton

  • Consulting Fees:
    Serves as consultant, advisory board member, or has received honoraria from: American Academy of Neurology, Alder, Allergan, American Headache Society, Amgen, Autonomic Technologies, Avanir, Biohaven, Biovision, Boston Scientific, Dr. Reddy’s, Electrocore, Eli Lilly, eNeura Therapeutics, GlaxoSmithKline, Merck, Pernix, Pfizer, Supernus, Teva, Trigemina, Vector, Vedanta.
    Equity:
    eNeura, Biohaven
    Lecture Fees:
    serves as consultant, advisory board member, or has received honoraria from: American Academy of Neurology, Alder, Allergan, American Headache Society, Amgen, Autonomic Technologies, Avanir, Biohaven, Biovision, Boston Scientific, Dr. Reddy’s, Electrocore, Eli Lilly, eNeura Therapeutics, GlaxoSmithKline, Merck, Pernix, Pfizer, Supernus, Teva, Trigemina, Vector, Vedanta.
    Grants
    • Agency: 
      Migraine Research Foundation
      Dates: 
      2015-2018
    • Agency: 
      Amgen
      Dates: 
      2018-present

Sara Rozner

  • Nothing to Disclose